All patients (n = 52) | Mild (n = 4) | Severe (n = 27) | Dead (n = 21) | P * | P ** | |||||
---|---|---|---|---|---|---|---|---|---|---|
Median (IQR) | Proportion, %, median (IQR) | Median (IQR) | Proportion, %, median (IQR) | Median (IQR) | Proportion, %, median (IQR) | Median (IQR) | Proportion, %, median (IQR) | |||
Total fee | 122 260 (60 710–310 220) | 100 | 12 790 (3 320–19 750) | 100 | 96 780 (56 780–287 140) | 100 | 228 650 (116 410–549 520) | 100 | <0.0001 | -- |
Examination | 8 420 (2 920–17 320) | 5.0 (2.5–10.6) | 530 (150–1 510) | 4.6 (3.5–9.4) | 8 660 (3 840–14 700) | 7.3 (3.2–11.6) | 13 900 (3 400–21 540) | 2.8 (1.6–9.9) | 0.011 | 0.092 |
Lab testing | 15 350 (8 520–35 570) | 11.9 (9.1–14.9) | 1 910 (290–3 390) | 16.3 (7.8–19.4) | 14 600 (8 470–27 950) | 13.2 (10.2–15.3) | 25 530 (11 120–65 980) | 9.7 (7.6–11.5) | 0.002 | 0.009 |
Medication | 63 250 (27 420–212 700) | 53.5 (40.1–60.1) | 8 080 (1 820–10 170) | 55.1 (34.8–65.3) | 61 130 (21 280–151 040) | 55.2 (47.0–59.8) | 137 410 (54 290–345 040) | 49.3 (38.0–60.6) | 0.001 | 0.868 |
Western medication | 58 390 (22 050–190 890) | 99.7 (90.6–100.0) | 3 520 (780–8 890) | 83.6 (36.0–95.9) | 55 750 (20 950–146 220) | 99.7 (94.6–100.0) | 137 220 (54 290–345 030) | 99.7 (91.1–100.0) | 0.001 | 0.420 |
TCMa | 340 (10–2 490) | 0.3(0 .0–3.4) | 300 (20–1 700) | 12.5 (2.2–19.5) | 330 (10–2 420) | 0.3 (0.0–3.3) | 350 (10–4 870) | 0.3 (0.0–2.5) | 0.812 | 0.358 |
Antibiotics | 12 880 (5 370–38 210) | 20.8 (11.1–36.3) | 2 740 (530–4 950) | 57.6 (22.4–68.3) | 13 260 (5 870–39 200) | 31.4 (16.1–39.0) | 19 060 (7 650–43 730) | 13.0 (8.1–30.5) | 0.014 | 0.018 |
Antiviral | 1 930 (840–4 130) | 2.5 (0.9–7.8) | 390 (20–790) | 7.5 (1.7–14.2) | 1 820 (980–4 140) | 2.9 (1.1–8.0) | 2 990 (1 390–4 780) | 1.2 (0.6–5.7) | 0.016 | 0.333 |
Glucocorticoids | 2 320 (340–8 560) | 2.3 (0.4–13.3) | 0 (0–1 930) | 0.0 (0.0–19.0) | 1 140 (270–6 700) | 1.3 (0.3–13.6) | 4 660 (1 620–22 830) | 4.1 (1.6–13.0) | 0.002 | 0.072 |
Immunoglobulin | 13 880 (0–33 400) | 10.4 (0.0–24.4) | 0 | 0.0 | 5 960 (0–39 100) | 10.4 (0.0–31.6) | 23 040 (8 290–39 780) | 17.0 (9.4–21.5) | 0.014 | 0.025 |
Treating | 13 860 (5 610–65 210) | 14.8 (8.3–23.8) | 120 (70–2 500) | 2.9 (0.8–12.9) | 8 770 (4 600–32 350) | 11.2 (7.7–18.3) | 54 450 (16 170–200 570) | 22.9 (14.8–29.8) | <0.0001 | 0.002 |
Medical Consumables | 1 010 (0–16 510) | 2.4 (0.0–12.2) | 300 (100–2 290) | 3.7 (2.2–11.8) | 150 (0–6 070) | 0.2 (0.0–5.9) | 21 630 (0–88 810) | 12.6 (0.0–19.1) | 0.025 | 0.020 |
Sick bed | 2 400 (1 340–3 990) | 1.4 (0.7–3.2) | 320 (1 650–5 260) | 4.4 (1.1–14.2) | 3 040 (1 430–5 150) | 2.1 (1.2–4.3) | 2 240 (1 410–3 520) | 0.8 (0.5–1.4) | 0.021 | 0.001 |
Nursing | 2 390(790–6 270) | 1.5 (0.7–3.3) | 340 (160–660) | 5.3 (0.9–18.9) | 3 170 (1 250–6 620) | 2.6 (1.1–4.8) | 2 180 (1 490–7 850) | 1.3 (0.7–1.5) | 0.050 | 0.033 |
Other fees | 100 (0–810) | 0.1 (0.0–1.1) | 10 (0–70) | 0.1 (0.0–0.3) | 310 (70–2 400) | 0.4 (0.1–2.0) | 60 (0–260) | 0.0 (0.0–0.2) | 0.022 | 0.032 |